Exploited vulnerability · CISA KEV
Yes. CVE-2023-38950, ZKTeco BioTime Path Traversal Vulnerability, is being exploited in the wild. CISA added it to its Known Exploited Vulnerabilities catalog on 19 May 2025, 655 days after it was published. It affects ZKTeco BioTime. If you run it, CISA's required action is: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
ZKTeco BioTime contains a path traversal vulnerability in the iclock API that allows an unauthenticated attacker to read arbitrary files via supplying a crafted payload.
| Vendor | ZKTeco (1 exploited CVE in KEV) |
| Product | BioTime |
| Vulnerability | ZKTeco BioTime Path Traversal Vulnerability |
| Weakness | CWE-22 |
| Published | 3 Aug 2023 |
| Added to KEV | 19 May 2025 |
| Reported by (CNA) | mitre |
Yes. CISA added CVE-2023-38950 to the Known Exploited Vulnerabilities catalog on 19 May 2025, which means there is reliable evidence of exploitation in the wild.
CISA does not list known ransomware use for it. That can change, and exploitation alone is reason to fix it first.
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable. Check ZKTeco's advisory for the fixed versions, and if you can't patch quickly, restrict access to the affected BioTime and watch it for signs of compromise.
Sources: CISA KEV (exploitation, ransomware use, required action, due date), the CVE record (publication date, CVSS, CNA), NVD and FIRST EPSS (live score). More: all KEV additions in May 2025 · act-now radar.
We check exposure across your estate, patch or mitigate with your team, and set up detection for what attackers do after exploiting it.
Get in touch →